Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

Paolo Catarsi, Francesca Cordero, Giulio Ferrero, Marco Beccuti, Valentina Poletto, Elisa Bonetti, PhD, Laura Villani, Margherita Massa, Gabriela Fois, Rita Campanelli, Umberto Magrini, Vittorio Rosti, Giovanni Barosi

Blood (2016) 128 (22): 4279.

https://doi.org/10.1182/blood.V128.22.4279.4279

Published: 2016

Journal Articles

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Laura Villani, BS,, Rita Campanelli, BS, Gabriella Gaudioso, BS, Valentina Poletto, PhD, Elisa Bonetti, PhD, Paolo Catarsi, BS, Gabriela Fois, BS, Benedetta G Erba, PhD, Margherita Massa, PhD, Umberto Magrini, MD, Giovanni Barosi, MD, Umberto Gianelli, MD, Vittorio Rosti, MD

Blood (2015) 126 (23): 2833.

https://doi.org/10.1182/blood.V126.23.2833.2833

Published: 2015

Journal Articles

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Giovanni Barosi, MD, Elisa Bonetti, BS, Paolo Catarsi, PhD, Margherita Massa, PhD, Rita Campanelli, Biol.Sci, Valentina Poletto, Biol.Sci, Gianluca Viarengo, MD, Laura Villani, Biol.Sci, Gabriela Fois, Biol.Sci, Flavia Biamonte, BiSci, PhD, Giada Rotunno, BiSci, Paola Guglielmelli, PhD MD, Umberto Magrini, MD, Alessandro M Vannucchi, MD, Vittorio Rosti, MD

Blood (2013) 122 (21): 4058.

https://doi.org/10.1182/blood.V122.21.4058.4058

Published: 2013

Journal Articles

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

Blood (2013) 121 (2): 360–368.

https://doi.org/10.1182/blood-2012-01-404889

Published: 2013

Includes: Supplemental data

Journal Articles

Prefibrotic Myelofibrosis (PreMF) Belongs to a Continuum of Epidemiological, Clinical and Histological Characteristics Featuring Primary Myelofibrosis (PMF)

Giovanni Barosi, MD, Vittorio Rosti, MD, Rita Campanelli, Biol. Sci, Paolo Catarsi, PhD, Antonina M. Isgrò, Lab Tech, Letizia Lupo, MD, Margherita Massa, Ph D, Valentina Poletto, Biol Sci, Gianluca Viarengo, MD, Laura Villani, Biol Sci, Umberto Magrini, MD

Blood (2011) 118 (21): 1743.

https://doi.org/10.1182/blood.V118.21.1743.1743

Published: 2011

Journal Articles

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Vittorio Rosti, MD, Elisa Bonetti, Gaetano Bergamaschi, MD, Rita Campanelli, PhD, Elisabetta Gattoni, MD, Sonia Lo Po, Umberto Magrini, MD, Margherita Massa, PhD, Alessandro Vannucchi, MD, Gianluca Viarengo, MD, Paola Guglielmelli, MD, Massimo Primignani, MD, Giovanni Barosi, MD

Blood (2009) 114 (22): 309.

https://doi.org/10.1182/blood.V114.22.309.309

Published: 2009

Journal Articles

Relationship between JAK2 V617F Mutation Status and Constitutive Mobilization of CD34-Positive Cells into Peripheral Blood in Patients with Chronic Myeloproliferative Disorder.

Francesco Passamonti, Elisa Rumi, Emanuela Boveri, Daniela Pietra, Laura Vanelli, Luca Arcaini, Matteo G. Della Porta, Cristiana Pascutto, Umberto Magrini, Mario Lazzarino, Mario Cazzola

Blood (2005) 106 (11): 2586.

https://doi.org/10.1182/blood.V106.11.2586.2586

Published: 2005

Journal Articles

Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.

Giovanni Barosi, MD, Monia Marchetti, MD, Margherita Massa, PhD, Vittorio Rosti, MD, Alessandro Vannucchi, MD, Rosangela Invernizzi, MD, Rita Campanelli, BSc, Gianluca Viarengo, MD, Umberto Magrini, PhD, Gaetano Bergamaschi, MD

Blood (2005) 106 (11): 256.

https://doi.org/10.1182/blood.V106.11.256.256

Published: 2005

Journal Articles

Molecular histogenesis of posttransplantation lymphoproliferative disorders

Daniela Capello, Michaela Cerri, Giuliana Muti, Eva Berra, Pierluigi Oreste, Clara Deambrogi, Davide Rossi, Giampietro Dotti, Annarita Conconi, Mario Viganò, Umberto Magrini, Giovanbattista Ippoliti, Enrica Morra, Annunziata Gloghini, Alessandro Rambaldi, Marco Paulli, Antonino Carbone, Gianluca Gaidano

Blood (2003) 102 (10): 3775–3785.

https://doi.org/10.1182/blood-2003-05-1683

Published: 2003

NARROW

Deregulated Genes in Hematopoietic Stem Cells Isolated from Spleen of Patients with Myelofibrosis

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

Prefibrotic Myelofibrosis (PreMF) Belongs to a Continuum of Epidemiological, Clinical and Histological Characteristics Featuring Primary Myelofibrosis (PMF)

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Relationship between JAK2 V617F Mutation Status and Constitutive Mobilization of CD34-Positive Cells into Peripheral Blood in Patients with Chronic Myeloproliferative Disorder.

Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.

Molecular histogenesis of posttransplantation lymphoproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only